Renal day 2 Flashcards

1
Q

Urine Output

A

Standards
Daily output averages 1000 – 2400 ml / day
Normal adult approximately 1500 mL/day
Acute Care Setting: 30 ml / hour (720 ml / day)

Oliguria: 100 – 400 ml / day
Aging kidney’s lose ability to concentrate
Older adults may be oliguric with volumes of 600 – 700 / day

Anuria: < 100 ml / day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acute Renal Failure: Causes

A

Primary causes in Acute Care:
Hypotension
Hypovolemia

Pre-Renal
Intra-Renal
Post-Renal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pre-Renal Causes

A

Issues that interfere with renal perfusion
Circulatory volume depletion
Volume shifts
“3rd Spacing”
Decreased cardiac output
Decreased PVR
Vascular Obstruction

General Symptoms
High specific gravity & osmolarity
Normal sediment
May have Hyaline/Granular casts
BUN / Cr significantly elevated (10:1 – 40:1)
Proteinuria & sodium excretion not significant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Intra-Renal Causes

A

Parenchymal changes caused by disease or nephrotoxins
Acute tubular necrosis (75%)
Muddy brown granular casts
Glomerulonephritis
Hematuria
RBC & Hemoglobin casts
Vascular lesions
Cortical necrosis (Prolonged vasospasm)
Tissue damage - Elevated
Serum creatinine
Phosphokinase
K+

General Symptoms:
Fixed specific gravity
Edema
Weight gain
Hemoptysis
Elevated LV EDP
Weakness (Anemia)
Hypertension
High urine sodium
Proteinuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Post-Renal Causes

A

Issues that cause obstruction of urinary tract
BPH
Calculi
Tumor
Surgical accident

Spinal cord injury
Neurogenic bladder with retention (decreased bladder emptying)
“Functional” obstruction

General Symptoms
Fixed specific gravity
Elevated urine sodium
Little or no proteinuria
Sediment normal
Indications of obstruction
Anuria / Polyuria: Intermittent?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Acute Kidney Injury: Elderly Considerations

A

Decreased GFR with aging

More susceptible to AKI & decreased ability to recover
Dehydration
Polypharmacy (Diuretics, laxatives)
Illness
Immobility
Hypotension, diuretic therapy, aminoglycoside therapy, obstructive disorders, surgery, infection, & contrast medium

Renal Replacement Therapies (RRT) still an option

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acute Kidney Injury: Oliguric Phase

A

U.O. < 400 ml / day
Occurs: 1 – 7 days of injury (24 - hours ischemia)
Duration: 10 – 14 days to months
Longer phase = poorer prognosis
50% patients non-oliguric; > 400 mL urine/day

Urinalysis; Casts, RBCs, WBCs, Protein

Specific gravity 1.010 (Fixed)

Osmolality 300 mOsm/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Acute Kidney Injury: Oliguric Phase cont

A

Hypovolemia may exacerbate AKI

Decreased urine output leads to fluid retention
Neck veins distended
Bounding pulse
Edema
Hypertension
Fluid overload can lead to:
CHF
Pulmonary edema
Pericardial or pleural effusions

Leukocytosis: Infection may be fatal
Urinary & respiratory
Waste product accumulation; Increased BUN & Cr

Neurologic disorders
Fatigue
Difficulty concentrating
Seizures, stupor, coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Metabolic acidosis

A

Kidneys cannot excrete Hydrogen or acid products of metabolism
Serum bicarbonate production decreased; Reabsorption & regeneration defective
Severe acidosis develops; Kussmaul respirations (increase exhaled CO2)

Results from
Impaired ability of kidneys to excrete excess acid
Defective reabsorption & regeneration of bicarbonate
Plasma bicarbonate level usually falls to approximately 16 to 20 mEq/L (16 to 20 mmol/L)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hyponatremia

A

Increased excretion of Na+ d/t damaged tubules
Can lead to cerebral edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hyperkalemia

A

Impaired ability to excrete K+
Usually asymptomatic; Peaked T waves, Wide QRS, ST depression
Increased risk with massive tissue trauma

Weakness, cardiac arrhythmias
EKG Monitoring / Remote Telemetry

Treatment:
K+ restriction
Potassium removal
Dialysis
Kayexalate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Acute Kidney Injury: Diuretic Phase

A

Lasts 1 – 3 weeks
Daily U.O. 1 - 3 Liters (up to 5 Liters)
Osmotic diuresis from high urea
Low specific gravity; Nearly iso-osmolar
Kidneys able to excrete waste, but not concentrate urine

Patients who develope oliguria will have greater diuresis than those who do not
Monitor for:
Hypovolemia,
Hypotension
Hyponatremia
Hypokalemia
Dehydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Acute Kidney Injury: Recovery Phase

A

Begins when GFR increases
Allows BUN & Cr to plateau & then decrease

Major improvements occur in first 1 – 2 weeks

May take up to 12-months to stabilize

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

AKI: Diagnostics

A

Thorough history
Serum BUN / Cr
Serum electrolytes
Urinalysis
Renal ultrasound
Renal CT scan
Renal biopsy

Contraindications: Contrast
MRI or MRA with Gadolinium (May be fatal)
Contrast-induced nephropathy
Metformin: Hold 48-hours before & after use of contrast; Risk for lactic acidosis
If contrast needed for high-risk patients - Use low-dose & ensure optimal hydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AKI: Interprofessional Care

A

Goals of Care:
Eliminate cause
Manage signs/symptoms
Prevent complications
Ensure adequate intravascular volume & cardiac output
Loop diuretics: Furosemide (Lasix)
Osmotic diuretics: Mannitol

Closely monitor fluid intake during Oliguric phase
Fluid restriction: All fluid losses for previous 24 hours + 600 mL
Expected outcomes:
Regain & maintain normal fluid & electrolyte balance
Adhere to treatment regimen
No complications
Complete recovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Electrolytes

A

K+ (3.5 – 5.0 mEq/L)
Na+ (136 – 145 mEq/L)
Mg+ (1.3 – 2.1 mEq/L)
Phosphorous (3.0 – 4.5 mg/dL)
Ca+ (Parathyroid function)
Total 9.0 – 10.5 mg/dL
Ionized 4.5 – 5.6 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Exchange Resins

A

Kayexalate & Sorbitol
Questions re: efficacy versus risks
Contra-indicated with ileus (Intestinal necrosis)

Patiromer (Veltassa)
Powder for oral suspension in water
Taken daily; Delayed action - Not for emergency use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Indications for Renal Replacement Therapy (RRT)

A

Volume overload
Hyperkalemia
Metabolic acidosis
BUN > 120 mg/dL
Significant change in mental status
Pericarditis, pericardial effusion, or cardiac tamponade
Clinical status of patient

Hemodialysis (HD): Emergent therapy
Peritoneal dialysis (PD)

ICU Setting Only:
Continuous Renal Replacement Therapy (CRRT)
Continuous cannulation (24-hours) of artery & vein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

AKI: Nutritional Therapy

A

Maintain adequate caloric intake
Primarily carbohydrates, increased fats, adequate protein to prevent breakdown
Restrict Na+, K+, Phosphate
Calcium supplements or phosphate-binding agents
Enteral / parenteral nutrition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Acute Care

A

Accurate I & O
Daily weights
Assess for hypervolemia or hypovolemia
Assess for K+ & Na+ disturbances
Meticulous aseptic technique
Careful use of nephrotoxic drugs
Skin care measures
Oral care

Patient Teaching for Post-Acute Ambulatory Care
Monitor kidney function
Regulate protein & potassium intake
Follow-up care
Teaching
Appropriate referrals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Chronic Kidney Disease (CKD)

A

Progressive, irreversible loss of kidney function
Low glomerular filtration rate (GFR); <60 mL/min/1.73m2 for longer than 3 months

More than 26 million American adults have CKD
Increased prevalence: Aging population, increased obesity, increased diabetes & HTN
Increased incidence: Blacks, Native Americans, & Latinos

Underdiagnoses & untreated; Many with CKD are asymptomatic; Approximately 70% aware

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Uremia

A

Syndrome; Kidney function declines to point that symptoms occur in multiple body systems

Often occurs when GFR is less than or equal to 15mL/min

Manifestations vary depending on cause, co-morbidities, age, & adherence to medical regimen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Diagnostic Studies

A

H & P
Dipstick evaluation of protein; Albuminuria
Urinalysis
Renal ultrasound, scan, CT scan, biopsy
Albumin-to-creatinine ratio (1st AM void)
Serum BUN, creatinine, creatinine clearance, electrolytes, lipids, hemoglobin, hematocrit
GFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Stages of Chronic Kidney Disease

A

1
≥ 90
Diagnosis and treatment; CVD risk reduction; slow progression

2
60–89
Estimation of progression

3a
45–59
Evaluation and treatment of complications

3b
30–44
More aggressive treatment of complications

4
15–29
Preparation for RRT (dialysis or transplant)

5
Less than 15 or dialysis
RRT if uremia present and patient desires treatment; necessary to maintain life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

CKD: Sodium / Magnesium

A

HYPOnatremia (Dilutional)
Confusion, seizures, coma
Fluid restriction for self-correction

HYPERmagnesemia
Decreased reflexes, mental status, B/P, respiratory failure
Avoid:
Dark green veggies
Grains, seeds, nuts
Legumes
Antacids with Mg+
Osmotic laxatives (Milk of Magnesia, Magnesium Citrate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

CKD: Calcium / Phosphorous

A

HYPOcalcemia
Decreased intestinal Ca+ absorption
Synthesis of 1,25 dihydroxyycholecalciferol
HYPERphosphatemia furthers low Ca+
Increased parathyroid hormone excretion leads to bone resorption
Osteomalacia
Osteitis fibrosa
Osteosclerosis

HYPERphosphatemia
Hypocalcemia
Increased risk for fractures, CKD-MBD
Avoid:
Dairy products & foods containing dairy products
Milk
Ice cream
Cheese
Yogurt
Pudding
Protein sources contain Phosphate
Phosphate binders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

As Glomerular Filtration Rate (GFR) Falls

A

Parathyroid hormone levels increase
Activated form of Vitamin D falls
Old thinking: This was just decreased production of 1,25(OH)2D

New understanding: Degradative pathways are up-regulated (some induced by FGF-23)
Fall in 1,25(OH)2D is physiological with CKD
Makes sense because you do not want a lot of 1,25(OH)2D around to cause more calcium & phosphorus absorption when you cannot excrete these ions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Mechanisms of CKD-MBD

A

Systemic disorder of mineral & bone metabolism results in:
Skeletal complications (Osteomalacia, osteitis fibrosa)
Soft tissue complications (Vascular calcifications)
Phosphate not restricted until patient requires RRT
Then Phosphate restricted to < 1 g/day

29
Q

Hypertension & Elevated Triglycerides

A

HTN; Cause & consequence of CKD
Aggravated by Na+ & H20 retention
Increased renin production may contribute
HTN, ECF volume overload, & anemia may develop into LV hypertrophy, which may lead to cardiomyopathy & HF
HTN can cause retinopathy, encephalopathy, nephropathy

B/P control; One of most important goals
Dysrhythmias; Hyperkalemia & Decreased coronary artery perfusion

Hyperinsulinemia stimulates hepatic production of triglycerides
Altered lipid metabolism
Decreased levels of enzyme lipase (Important in breakdown of lipoproteins)
Increased VLDLs & LDLs
Decreased HDLs

30
Q

CKD & CV Disease Are Closely Linked

A

Death often r/t MI, ischemic heart disease, PAD, HF, cardiomyopathy, and/or stroke

Traditional CV risk factors; HTN & Elevated lipids
Nontraditional CV risk factors; Vascular calcification & arterial stiffness
Calcium deposits associated with stiff blood vessels
Vascular smooth muscle cells change
High Ca+ & phosphate
Impaired renal excretion
Drug therapies to treat bone disease

31
Q

Altered Carbohydrate Metabolism

A

Caused by impaired glucose metabolism (Cellular insensitivity to normal action of insulin)
Mild-moderate hyperglycemia
Hyperinsulinemia

Uremic patients with DM may require less insulin than before onset of CKD
Excretion of insulin dependent on kidneys
Insulin dosing must be individualized
May improve after starting dialysis

32
Q

CKD: Hematologic Changes

A

Decreased production of erythropoietin
Other factors:
Nutritional deficiencies
Decreased RBC life span,
HD & Increased hemolysis
Blood sampling
GI bleeding
Increased Parathyroid hormone
Decreased iron stores
Folic acid lost in dialysis

Bleeding tendencies
Defect in platelet function
Infection
Change in WBC function
Altered immune response & function
Hyperglycemia
External trauma

33
Q

CKD: Every Part of GI System Affected

A

Cause: Excessive Urea
Stomatitis with exudates & ulcerations
Uremic fetor (Urine odor to breath)
Anorexia, nausea, vomiting
Diabetic gastroparesis
GI bleeding
Constipation significant problem
Phosphate-binding medications are constipating
Cannot be managed by increasing PO fluids, or taking Magnesium or fiber / bulk forming laxatives
Probiotics, stool softeners, use of footstool when defecating

34
Q

CKD: CNS Manifestations

A

CNS depression
Lethargy, apathy
Decreased ability to concentrate
Fatigue, irritability
Altered mental ability (late sign)
Seizures
Coma
Hypertensive encephalopathy

Peripheral neuropathy
Restless legs syndrome
Paresthesias
Motor involvement
Foot drop
Muscle weakness & atrophy
Loss of deep tendon reflexes
Muscle twitching, jerking, asterixis, & nocturnal leg cramps

35
Q

CKD: Metabolic Changes

A

Carbohydrate intolerance
Peripheral insulin antagonism
Impaired insulin secretion
Prolonged insulin half-life
Abnormal circulating insulin
** Short acting insulin functions as longer acting
** Patients on dialysis may need less insulin for glucose control
Elevated triglycerides
Metabolic acidosis
Pericarditis

36
Q

Acid-Base Balance

A

Normal pH: 7.35 – 7.45
Normal Base Excess: 0 +/- 3 mEq / L
Calculated with ABG results using pH, PC02 & HCT
Represents amount of buffering ions in blood
Largest = HCo3-
Hemoglobin, Proteins, Phosphates, Etc…

Negative (-) BE indicates metabolic (lactic) acidosis

Positive (+) BE indicates metabolic alkalosis or compensation to respiratory acidosis

37
Q

CKD: Reproductive & Other Manifestations

A

Infertility & decreased libido
Experienced by both sexes: Low sperm counts, amenorrhea
Sexual dysfunction; Physical, psychological, & medication side effects
Pregnancy during dialysis poses significant risk to mother & fetus

Pruritus
Calcium-phosphate deposits
Sensory neuropathy
May be intense
Leads to bleeding or infection
Uremic frost
Urea crystalizes on skin
BUN > 200 mg/dL

38
Q

CKD: Renal Diet

A

Adequate calories
30 – 35 kcal / Kg
Primarily from Carbs & Fat (30 – 40% to prevent / reduce catabolism)
Protein
0.8 – 1.0 Gm / Kg / day
Avoid high-protein, fad diets
Greater needs in end-stage

K+ / Na+ regulated to plasma levels
Restrict Na+ to prevent edema
Phosphate restriction
1 gram per day
Avoid foods high in phosphate (Meat & dairy)
Most foods high in phosphate are high in protein
Phosphate binders essential with dialysis

39
Q

CKD: Interprofessional Care

A

Overall goals
Preserve existing kidney function
Reduce risks of CV disease
Prevent complications
Provide for comfort
Early recognition and treatment important
Nephrology referral
Identify & treat reversible causes

Management Stage 1 to 4: Control:
HTN
Hyperparathyroidism
CKD-MBD
Anemia
Dyslipidemia
Correct ECF overload or deficit
RRT
Treat CV disease
Nutritional therapy
Drug therapy

40
Q

Medications for CRF

A

Antihypertensives
Diuretics
Calcium
Prophylactic antibiotics
Vitamins, Minerals & Phosphate binders

41
Q

Antihypertensives: Angiotension-Converting Enzyme (ACE) Inhibitors

A

Slow progression or delay onset of Diabetic nephropathy (Example: Captopril)

Dilate arterioles & veins
Reduce blood volume (effect on kidneys)
Reduce glomerular filtration pressure
Suppress formation of Angiotension II
1st dose hypotension
Hyperkalemia
Vasodilation
Increase bradykinin (Inhibit Kinase II)
Cough & angioedema

42
Q

Angiotension II Receptor Blockers (ARB’s)

A

Prevent Angiotension II mediated vasoconstriction & release of Aldosterone

Produce effects similar to ACE inhibitors
No cough
No angio-edema

Diabetic nephropathy
Irbesartan (Avapro)
Losartan (Cozaar)

43
Q

Diuretics

A

Furosemide (Lasix)
Blocks re-absorption of Na+ & Cl- at ascending LOH
Diuresis despite low renal blood flow & GFR
Onset: 5-minutes
Duration: 2-hours
Hypotension
Hypokalemia
Ototoxicity (IVP: 20 - 40 mg over 1 - 2 minutes)

Mannitol (5% - 25%)
Creates osmotic force within nephron
Diuresis of fluid only
Onset: 30 – 60 minutes
Duration: 6 – 8 hours
Edema
May precipitate CHF / Pulmonary edema
Observe for crystals
Filter needle

44
Q

Medications for Dyslipidemia

A

Statins (HMG-CoA reductase inhibitors)
Most effective for lowering LDL
Atorvastatin (Lipitor)

Fibrates (Fibric acid derivatives)
Used to lower triglyceride levels & increase HDL
Gemfibrozil (Lopid)

45
Q

Vitamins, Minerals & Binders

A

Calcium

Cinacalcet (Sensipar)
Increases sensitivity of Ca+ receptors in parathyroid glands
Subtotal or total parathyroidectomy

Vitamin D: Calcitriol (Rocaltrol)
0.5 – 1.0 mcg / daily
Treats hypoparathyroidism & hypocalcemia
Serum phosphate must be lowered before Calcium or Vitamin D is administered
Avoid aluminum & magnesium preparations

Folic Acid

Phosphate binders (Reduce intestinal absorption)
Bind phosphate in bowel & then excrete
Ca+ based
Calcium carbonate (Caltrate)
Calcium acetate (PhosLo)
Ca+ free
Sevelamer (Renagel) – Lowers cholesterol & LDL

46
Q

Treatments for Anemia

A

Iron supplements
If plasma ferritin <100 ng/mL
Side effects: GI irritation, constipation
May make stool dark in color

Folic acid supplements
Needed for RBC formation
Removed by dialysis

Avoid blood transfusions
Increase development of antibodies
May lead to iron overload

Epoetin alfa (Epogen, Procrit)
Darbepoeitin alfa (Aranesp)
Given IV or SQ
Expect increased H & H in 2 - 3 weeks
Side effects:
Thromboembolism, HTN

47
Q

Inter-dialetic Weight Gain

A

Weight gain between dialysis treatments
Rationale for fluid restriction
Measure of adherence

1 – 3 Kg advised (2.2 to 6.6 pounds)

48
Q

Fluid & Electrolyte Balance

A

Careful fluid replacement
Calculated fluid restriction = 24-hour loss + 600 ml insensible
Daily weights

Fluid restriction (1000 – 1500 mL / Day)

Diuretics
Furosemide (Lasix)
Bumetanide (Bumex)
Mannitol

49
Q

Managing Fluid Restriction in Acute Care

A

1000 – 1500 mL/day (Average fluid restriction for CKD)

Acute Care RN responsible to supervise & maintain ordered fluid restriction from all sources:
PO
Enteral nutrition, & free water flushes
Parenteral nutrition
Maintenance IV
Continuous IV medications (Ex: Heparin, Nexium)
Intermittent IV medications (Ex: Antibiotics, others)

50
Q

Dialysis Access: A Dialysis Patient’s Life Line

A

Temporary Dialysis Catheter
Double-lumen, non-tunneled CVAD
13 – 20 cm long, 13G or less, No cuff, Rigid
Permanent Dialysis Catheter (“PermCath”)
Tunneled, cuffed at skin/exit site
Arterio-venous Fistula (AVF)
Arterio-venous Graft (AVG)
HeRO Graft
Used when other options have failed
Bypasses venous system; blood flow directly from target artery from the heart
More difficult to assess Thrill / Bruit d/t no venous anastomosis
Peritoneal Dialysis Catheter

51
Q

Temporary Vascular Access

A

Insertion at internal jugular or femoral vein when immediate access needed
Double lumen
Blood removal
Blood return
Risks:
Infection
Dislodgment
Malfunction

52
Q

Assessment of Dialysis Access

A

A-V Fistula

A-V Graft

Assess for bleeding / bruising (after Hemodialysis)
Assess for patency
Auscultate for “Bruit”
Palpate for “Thrill”

53
Q

Dry Weight

A

Usually reflects lowest weight a patient can tolerate without intra-dialytic symptoms or hypotension
Imprecise trial-and-error method
Does not account for changes in nutritional status & lean body mass
Difficult to determine over- or under-hydration
Used to calculate ultra-filtration (UF) volume & rates for dialysis treatment

54
Q

Physiologic Dry Weight

A

Weight resulting from
Normal renal function
Vascular permeability
Serum protein concentration
Body volume regulation
Patients theoretically should be lower than physiologic to be prophylactic for inter-dialytic weight gain

55
Q

Renal Replacement Therapies (RRT)

A

Intermittent (Hemodialysis, Peritoneal dialysis)
Continuous (CRRT) in Critical Care
Toxins/fluids removed
Acid-Base balance & electrolytes adjusted slowly in hemodynamically UNSTABLE patients
Access: Double-lumen catheter in Jugular or Femoral veins
Blood pump & anti-coagulation required
Renal Transplantation

56
Q

Funding for Chronic Diseases

A

1972 Social Security Amendment - Medicare Coverage for all those:
65 or older
Under 65 with certain disabilities (DM, HTN) & those who have received Social Security Disability (SSDI) for 2-years
Any age with ESRD
1978: Congress established ESRD Network Organizations Program
1986: Program re-codified to 18 ESRD Network Organization areas, Funding for Renal Transplantation

57
Q

Dialysis

A

Movement of fluid/molecules across semipermeable membrane from one compartment to another
Used to correct fluid & electrolyte imbalances, & remove waste products in kidney failure
Can be used to treat drug overdoses
Two methods available
Peritoneal dialysis (PD)
Hemodialysis (HD)
Nephrologist determines when to start; Usually uremia can no longer be adequately treated conservatively; GFR < 15 mL/min/1.73 m2
Uremic complications require dialysis
ESRD treated with dialysis because
Lack of donated organs
Some patients are physically or mentally unsuitable for transplantation
Some patients do not want transplantation

58
Q

General Principles of Dialysis

A

Diffusion; Movement of solutes from an area of greater concentration to an area of lesser concentration
Osmosis; Movement of fluid from an area of lesser concentration of solutes to area of greater concentration
Glucose in dialysate creates osmotic gradient to pull fluid from the blood
Ultrafiltration; Water & fluid removal results when there is an osmotic gradient or pressure gradient across membrane, excess fluid moves into dialysate
PD: Glucose in dialysate
HD: Pressure gradient

59
Q

Peritoneal Dialysis

A

Access obtained by inserting catheter through anterior abdominal wall
Technique for placement varies; usually done via surgery
PD may start right away or be delayed until site healed
Aseptic technique important to avoid peritonitis

60
Q

Peritoneal Dialysis: Dialysis Solutions & Cycles

A

Dextrose in dialysis solution; Osmotic agent
Manual PD: 3-Phase Cycle (Called an “Exchange”)
Volume depends on size of peritoneal cavity
Inflow (fill); 2 to 3 Liters over 10-minutes
Dwell (equilibration); 20 - 30 minutes to 8-hours (Individualized)
Drain; 15 - 30 minutes
Continuous Ambulatory Peritoneal Dialysis (CAPD)
Manual exchange 4 x / Day
Automated Peritoneal Dialysis (APD)
Cycler delivers dialysate during sleep
Times & controls fill, dwell, & drain phases
Alarms & monitors for safety

61
Q

Peritoneal Dialysis Complications

A

Exit site infection
Redness, tenderness, drainage
Treated with antibiotics
Peritonitis: Exit site or tunnel infection
Abdominal pain, rebound tenderness
Cloudy effluent with increased WBCs or bacteria, may have fever
GI: diarrhea, vomiting, distention, hyperactive bowel sounds
Treated with antibiotics
Repeated infections may cause adhesions
Hernias: Increased intra-abdominal pressure from dialysate
Treatment: hernia repair

Bleeding
Common with initial catheter placement
New; Active intraperitoneal bleeding; check BP & hematocrit
Pulmonary complications
Decreased lung expansion leads to atelectasis, pneumonia, or bronchitis
Elevate HOB, repositioning & deep breathing
Protein loss; Monitor nutrition
Lower back problems
Intraperitoneal infusion increases pressure
Treatment: binders and exercise

62
Q

Peritoneal Dialysis – Effectiveness of Chronic PD

A

Short training program; 3 to 7 days
Advantages
Simplicity
Home-based program
Increasing patient participation
No need for special water systems
Equipment set-up is relatively simple

63
Q

Hemodialysis (HD) Vascular Access

A

Requires rapid blood flow & access to large blood vessel
Obtaining vascular access is one of most difficult problems

AV Fistula: Created in forearm or upper arm; Preferred access for HD
Allows arterial blood to flow through vein; becomes “arterialized; Increases vein size & wall thickness
Placed 3-months before HD; Needs to heal/mature
“Thrill” & “Bruit” (High velocity blood flow)
AV Graft: Synthetic material surgically placed under skin to form a “bridge” between brachial artery & antecubital vein

Temporary vascular access

64
Q

AV Fistulas & Grafts

A

Healing: 2 to 4 weeks
More likely to get infected or form clots
If infected, may need removed
Risks:
Distal ischemia (Steal Syndrome)
Pain distal to access site
Numbness or tingling of fingers
Poor capillary refill
Aneurysms
Safety alert for AVF & grafts
No BP, venipunctures, or IV lines
Post signs in room & labeled arm band
Prevent infection & clotting

HeRO Graft (Hemodialysis Reliable Outflow)
Special bridge access used when other access options are exhausted
Two pieces
Reinforced tube to bypass blockages
Dialysis graft anastomosed to an artery; placed under skin
Bypasses venous system; blood flows from target artery to heart

65
Q

Hemodialysis Dialyzer

A

Plastic cartridges that contain thousands of parallel hollow tubes or fibers; semipermeable membranes
Blood is pumped from top into fibers
Dialysate pumped from bottom & bathes outside of fibers
Ultrafiltration, diffusion & osmosis occur
When blood reaches end it is returned via single tube to patient

66
Q

Hemodialysis Procedure

A

Fluid status assessed before HD treatment
Weight, BP, peripheral edema, heart & lung sounds
Last post-dialysis weight & current pre-dialysis weight determines amount of fluid to be removed
Assess vascular access & temperature
Two large bore needles placed in fistula or graft
One to pull blood from circulation to HD machine
Other to return dialyzed blood to patient
Dialyzer/blood lines primed with NaCL to eliminate air; Heparin added to prevent clotting
Dialysate delivery & monitoring system is used; VS every 30 - 60 minutes, Terminated with saline flush to return all blood to patient, Needles removed & firm pressure applied
Most in community-based center; Dialyzed 3 - 4 hours, 3 days/week
Other options; Short daily HD, Long nocturnal HD, Home HD

67
Q

Hemodialysis Complications

A

Hypotension; Hypovolemia, decreased CO & SVR; Light-headed, nausea, seizures, vision changes, & chest pain
Treatment: Decrease volume of fluid removal & IV Normal Saline
Muscle cramps; Decreased BP, hypovolemia, increased ultrafiltration, & low-sodium dialysate
Treatment: Decrease ultrafiltration & give IV fluids
Blood loss; Blood not rinsed from dialyzer, accidental separation of tubing, dialysis membrane rupture or bleeding after needles removed; Heparin
Treatment: Rinse all blood back, avoid excess Heparin, hold pressure to access sites
Hepatitis C (8% to 10% develop): Infection control precautions
Hepatitis B: low incidence; administer vaccine

68
Q

Hemodialysis Effectiveness

A

Cannot fully replace normal function of kidneys
Can ease many of symptoms
Can prevent certain complications
CV disease carries high mortality rate
Infectious complications 2nd leading cause of death

Individual adaptation
Positive
Ambivalent
Depressed
Nursing goals:
Help patient to:
have a healthy self-image
return to highest level of function

69
Q

Wearable Artificial Kidney (WAK)1st Clinical Trial 2015 – 7 Patients

A

Battery operated
Requires only 370 mL water
Versus 40-gallons for HD
Early model 11-pounds
Latest model 2-pounds
Device connected via one catheter surgically inserted in 20-minute procedure under a local anesthetic